Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / EGRX - Eagle Pharmaceuticals reiterates 2023 adjusted non-GAAP EBITDA

EGRX - Eagle Pharmaceuticals reiterates 2023 adjusted non-GAAP EBITDA

Eagle Pharmaceuticals Inc.

2023-08-17 07:02:06 ET

  • Eagle Pharmaceuticals Inc ( NASDAQ: EGRX ) Thursday reiterated its previously issued guidance for the 2023 fiscal year.
  • Says full-year 2023 adjusted non-GAAP EBITDA is expected to range from $78.0 to $84.0 million and adjusted non-GAAP earnings per share is expected to range from $4.40 to $4.70.
  • Source: Press Release

For further details see:

Eagle Pharmaceuticals reiterates 2023 adjusted non-GAAP EBITDA
Stock Information
Company Name: Eagle Pharmaceuticals Inc.
Stock Symbol: EGRX
Market: NASDAQ
Website: eagleus.com
Menu
EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...